Meinian Onehealth projects significant net profit growth for first three quarters

Meinian Onehealth Healthcare Holdings expects its net profit attributable to shareholders for the first three quarters of 2025 to range from 4,200m yuan to 6,200m yuan, a robust increase of 70.51% to 151.70% compared to the previous year. This growth is projected despite an anticipated decline in operating revenue, estimated between 68,500m yuan and 70,100m yuan, a decrease of 1.83% to 4.07% from the prior year. Basic earnings per share are forecasted to be 0.01 yuan to 0.02 yuan.

For the third quarter alone, net profit attributable to shareholders is projected between 26,336.31m yuan and 28,336.31m yuan, an increase of 9.55% to 17.87% year-on-year. This positive outlook is attributed to the peak season for physical examinations, the company's proactive efforts in increasing revenue and examination volume, stable order signing, and enhanced customer retention. AI-driven revenue, particularly from technologies like cardio-pulmonary screening and AI-MDT reports, contributed 24,963.84m yuan, up 71.02% year-on-year.

The company also highlights its continued commitment to AI and digital empowerment, along with cost reduction and efficiency improvement measures. These strategies aim to bolster specialized medical examinations and post-examination health management, creating an integrated, lean operational system for medical services, marketing, and management.